1.
Open Forum Infect Dis
; 11(6): ofae158, 2024 Jun.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38887477
RESUMO
Among solid organ transplant recipients taking belatacept, 15% developed invasive fungal diseases. The most common invasive fungal diseases were aspergillosis (56%) and candidiasis (22%). The infected cohort was more likely to receive basiliximab, undergo lung transplantation, or identify as White. Higher rates of aspergillosis were seen in this lung cohort than previously reported.